| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C W Ritchie, E Chiu, S Harrigan, S MacFarlane, M Mastwyk, G Halliday, H Hustig, K Hall, A Hassett, D W O'Connor, J Opie, V Nagalingam, J Snowdon, D Ame. A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. International journal of geriatric psychiatry. vol 21. issue 2. 2006-08-01. PMID:16416458. |
a comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. |
2006-08-01 |
2023-08-12 |
Not clear |
| C W Ritchie, E Chiu, S Harrigan, S MacFarlane, M Mastwyk, G Halliday, H Hustig, K Hall, A Hassett, D W O'Connor, J Opie, V Nagalingam, J Snowdon, D Ame. A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration. International journal of geriatric psychiatry. vol 21. issue 2. 2006-08-01. PMID:16416458. |
following an earlier study in which elderly patients with schizophrenia had their typical antipsychotic medication changed to olanzapine or risperidone, the 61 patients were followed for up to a further six months to see if either treatment was superior in terms of efficacy or side effects. |
2006-08-01 |
2023-08-12 |
Not clear |
| Catherine J Bresee, Katia Delrahim, Rachel E Maddux, Douglas Dolnak, Oliver Ahmadpour, Mark Hyman Rapapor. The effects of celecoxib augmentation on cytokine levels in schizophrenia. The international journal of neuropsychopharmacology. vol 9. issue 3. 2006-07-27. PMID:16035956. |
twenty-eight schizophrenia subjects stabilized on olanzapine or risperidone were randomized to receive 8 wk of celecoxib (400 mg/d) or placebo. |
2006-07-27 |
2023-08-12 |
human |
| Bruce J Kinon, Jonna Ahl, Hong Liu-Seifert, Gerald A Maguir. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Psychoneuroendocrinology. vol 31. issue 5. 2006-07-20. PMID:16488084. |
improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. |
2006-07-20 |
2023-08-12 |
Not clear |
| Neil D Woodward, Scot E Purdon, Herbert Y Meltzer, David H Zal. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15784157. |
a meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. |
2006-07-19 |
2023-08-12 |
human |
| Robert A Lasser, Cynthia A Bossie, Georges M Gharabawi, Ross J Baldessarin. Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial. The international journal of neuropsychopharmacology. vol 8. issue 3. 2006-07-19. PMID:15804371. |
this open trial of long-acting risperidone involved 336 patients diagnosed with dsm-iv schizophrenia or schizoaffective disorder judged clinically stable on a consistent daily oral dose of risperidone for > or =4 wk. |
2006-07-19 |
2023-08-12 |
human |
| Georges M Gharabawi, Robert A Lasser, Cynthia A Bossie, Young Zhu, Xavier Amado. Insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. International clinical psychopharmacology. vol 21. issue 4. 2006-06-29. PMID:16687995. |
insight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. |
2006-06-29 |
2023-08-12 |
Not clear |
| David Murdoch, Gillian M Keatin. Sertindole : a review of its use in schizophrenia. CNS drugs. vol 20. issue 3. 2006-06-28. PMID:16529528. |
sertindole is at least as effective as haloperidol and risperidone in the treatment of neuroleptic-responsive schizophrenia. |
2006-06-28 |
2023-08-12 |
Not clear |
| M B Jayaram, P Hosalli, S Strou. Risperidone versus olanzapine for schizophrenia. The Cochrane database of systematic reviews. issue 2. 2006-06-15. PMID:16625629. |
risperidone versus olanzapine for schizophrenia. |
2006-06-15 |
2023-08-12 |
Not clear |
| Deanna L Kelly, Robert R Conle. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology. vol 31. issue 3. 2006-06-08. PMID:16198059. |
a randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. |
2006-06-08 |
2023-08-12 |
human |
| Deanna L Kelly, Robert R Conle. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia. Psychoneuroendocrinology. vol 31. issue 3. 2006-06-08. PMID:16198059. |
this report contains data for 27 people with schizophrenia who participated in a randomized double-blind 12-week trial of risperidone (4 mg/day), quetiapine (400 mg/day) or fluphenazine (12.5 mg/day). |
2006-06-08 |
2023-08-12 |
human |
| Jong-Hoon Kim, Seong-Youn Kim, Yong Min Ahn, Yong Sik Ki. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 30. issue 2. 2006-06-08. PMID:16309807. |
subjective response to clozapine and risperidone treatment in outpatients with schizophrenia. |
2006-06-08 |
2023-08-12 |
human |
| Joseph P McEvoy, Jeffrey A Lieberman, T Scott Stroup, Sonia M Davis, Herbert Y Meltzer, Robert A Rosenheck, Marvin S Swartz, Diana O Perkins, Richard S E Keefe, Clarence E Davis, Joanne Severe, John K Hsia. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. The American journal of psychiatry. vol 163. issue 4. 2006-05-24. PMID:16585434. |
effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. |
2006-05-24 |
2023-08-12 |
Not clear |
| T Scott Stroup, Jeffrey A Lieberman, Joseph P McEvoy, Marvin S Swartz, Sonia M Davis, Robert A Rosenheck, Diana O Perkins, Richard S E Keefe, Clarence E Davis, Joanne Severe, John K Hsia. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. The American journal of psychiatry. vol 163. issue 4. 2006-05-24. PMID:16585435. |
effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic. |
2006-05-24 |
2023-08-12 |
Not clear |
| Uriel Heresco-Lev. Adding sarcosine, but not D-serine, to risperidone improves symptoms in people with acute phase schizophrenia. Evidence-based mental health. vol 9. issue 2. 2006-05-18. PMID:16638897. |
adding sarcosine, but not d-serine, to risperidone improves symptoms in people with acute phase schizophrenia. |
2006-05-18 |
2023-08-12 |
Not clear |
| Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Rolf R Engel, Richard Musil, Sandra Dehning, Anette Douhet, Markus J Schwarz, Hans-Jürgen Mölle. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. European archives of psychiatry and clinical neuroscience. vol 255. issue 6. 2006-05-17. PMID:16267634. |
quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. |
2006-05-17 |
2023-08-12 |
Not clear |
| Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Rolf R Engel, Richard Musil, Sandra Dehning, Anette Douhet, Markus J Schwarz, Hans-Jürgen Mölle. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. European archives of psychiatry and clinical neuroscience. vol 255. issue 6. 2006-05-17. PMID:16267634. |
we therefore investigated risperidone and quetiapine with respect to their efficacy against negative symptoms in a 12-week,double-blind, comparative pilot study involving 44 patients with schizophrenia with predominantly negative symptoms, as defined by positive and negative syndrome scale (panss) scores. |
2006-05-17 |
2023-08-12 |
Not clear |
| Michael Riedel, Norbert Müller, Martin Strassnig, Ilja Spellmann, Rolf R Engel, Richard Musil, Sandra Dehning, Anette Douhet, Markus J Schwarz, Hans-Jürgen Mölle. Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptoms. European archives of psychiatry and clinical neuroscience. vol 255. issue 6. 2006-05-17. PMID:16267634. |
in conclusion, there is no significant difference in efficacy between quetiapine and risperidone in alleviating the negative symptoms of schizophrenia. |
2006-05-17 |
2023-08-12 |
Not clear |
| Jean-Pierre Lindenmayer, Mohan Parak, Jack M Gorma. Improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response. Journal of psychiatric practice. vol 12. issue 1. 2006-05-04. PMID:16432447. |
improved long-term outcome with long-acting risperidone treatment of chronic schizophrenia with prior partial response. |
2006-05-04 |
2023-08-12 |
Not clear |
| Ronnachai Kongsakon, Thawatchai Leelahanaj, Natalia Price, Liesl Birinyi-Strachan, Peter Dave. Cost analysis of the treatment of schizophrenia in Thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. vol 88. issue 9. 2006-05-04. PMID:16536115. |
cost analysis of the treatment of schizophrenia in thailand: a simulation model comparing olanzapine, risperidone, quetiapine, ziprasidone and haloperidol. |
2006-05-04 |
2023-08-12 |
Not clear |